seed
Stage
2018
Founded
1
Investors
About
NectinTx develops novel immuno-oncology therapies including antibodies and antibody-drug conjugates aimed at overcoming resistance to existing cancer immunotherapies.
Explore NectinTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.